Katsura, H., Suga, Y., Araya, T., Kita, T., Yoneda, T., Tanaka, N., . . . Mase, H. (2019). Efficacy and Safety of Nivolumab in Patients with Advanced Non-small-cell Lung Cancer and Poor Performance Status. J Cancer.
Styl cytowania ChicagoKatsura, Hideyuki, Yukio Suga, Tomoyuki Araya, Toshiyuki Kita, Taro Yoneda, Nobuyoshi Tanaka, Ayumi Kawabata, Sotoki Ishita, i Hiroki Mase. "Efficacy and Safety of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer and Poor Performance Status." J Cancer 2019.
Styl cytowania MLAKatsura, Hideyuki, et al. "Efficacy and Safety of Nivolumab in Patients With Advanced Non-small-cell Lung Cancer and Poor Performance Status." J Cancer 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..